Literature DB >> 32207078

Risk Factors for Readmission after Ileostomy Creation: an NSQIP Database Study.

Na Eun Kim1, Jason F Hall2.   

Abstract

BACKGROUND: Ileostomy creation is associated with excess readmissions following colorectal surgery. This study identifies risk factors for readmission in patients undergoing ileostomy creation and identifies areas of clinical intervention to reduce readmission.
METHODS: We used the NSQIP dataset including colectomy specific data to include 39,380 patients who underwent ileostomy creation between 2012 and 2017. We conducted univariate and multivariable analysis to identify predictors of surgery-related 30-day readmissions. Our multivariate model included surgery type (total abdominal colectomy, partial colectomy, enterectomy, or pelvic dissection), gender, age, race, ethnicity, preoperative renal failure, dialysis, transfusion, ascites, ventilator dependence, diabetes, ASA class, functional status, emergency case, SSI, wound disruption, postoperative renal insufficiency, postoperative sepsis, discharge destination, and wound class.
RESULTS: A total of 5718 (14.52%) patients were readmitted within 30 days. After multivariate analysis, factors associated with readmission were gender, age, Hispanic ethnicity, dialysis, transfusion, ventilator dependence, diabetes, emergency case, SSI, postoperative renal insufficiency, postoperative sepsis, and discharge to a skilled facility. Patients who had enterectomy and partial colectomies were less likely to be readmitted than patients who had a pelvic procedure. Patients with postoperative renal insufficiency or renal failure were much more likely to be readmitted.
CONCLUSION: Factors associated with readmission included the type of procedure and postoperative complications such as SSI, sepsis, and renal failure. Efforts to reduce readmission should focus on patients undergoing concomitant pelvic procedures as well as avoidance and management of common complications in this group of patients.

Entities:  

Keywords:  Ileostomy creation; Readmission

Mesh:

Year:  2020        PMID: 32207078     DOI: 10.1007/s11605-020-04549-y

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  4 in total

1.  Evaluating the degree of difficulty of laparoscopic colorectal surgery.

Authors:  Faek R Jamali; Asaad M Soweid; Hani Dimassi; Charles Bailey; Joel Leroy; Jacques Marescaux
Journal:  Arch Surg       Date:  2008-08

2.  Wound complications in rectal cancer patients undergoing primary closure of the perineal wound after abdominoperineal resection.

Authors:  Galal El-Gazzaz; Ravi Pokala Kiran; Ian Lavery
Journal:  Dis Colon Rectum       Date:  2009-12       Impact factor: 4.585

3.  Factors predicting hospital length-of-stay and readmission after colorectal resection: a population-based study of elective and emergency admissions.

Authors:  Maria Kelly; Linda Sharp; Fiona Dwane; Tracy Kelleher; Harry Comber
Journal:  BMC Health Serv Res       Date:  2012-03-26       Impact factor: 2.655

4.  Early postoperative complications have long-term impact on quality of life after restorative proctocolectomy.

Authors:  Andrew McCombie; Yun Lee; Rutvik Vanamala; Richard Gearry; Frank Frizelle; Emma McKay; Jonathan Williman; Tim Eglinton
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

  4 in total
  2 in total

1.  Failure to Thrive Following Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy: Causes and Consequences.

Authors:  Caroline J Rieser; Jurgis Alvikas; Heather Phelos; Lauren B Hall; Amer H Zureikat; Andrew Lee; Melanie Ongchin; Matthew P Holtzman; James F Pingpank; David L Bartlett; M Haroon A Choudry
Journal:  Ann Surg Oncol       Date:  2022-01-06       Impact factor: 5.344

Review 2.  Overall readmissions and readmissions related to dehydration after creation of an ileostomy: a systematic review and meta-analysis.

Authors:  I Vogel; M Shinkwin; S L van der Storm; J Torkington; J A Cornish; P J Tanis; R Hompes; W A Bemelman
Journal:  Tech Coloproctol       Date:  2022-02-22       Impact factor: 3.699

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.